Publications

Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor

Publié en February 2023 European Journal of Medicinal Chemistry
February 2023

Reduced Intestinal Inflammation With Lumacaftor/Ivacaftor in Adolescents With Cystic Fibrosis

European Journal of Medicinal Chemistry
Previous publication
February 2023

Dietary intake assessment in children with cystic fibrosis using 3-day food diaries: a single-centre study

European Journal of Medicinal Chemistry
Next publication

Authors

  • Martina De Pascale
    Lukas Bissegger
    Chiara Tarantelli
    Florent Beaufils
    Alessandro Prescimone
    Hayget Mohamed Seid Hedad
    Omar Kayali
    Clara Orbegozo
    Luka Raguž
    Thorsten Schaefer
    Paul Hebeisen
    Francesco Bertoni
    Matthias P. Wymann
    Chiara Borsari